Public Affairs & Media Relations
Research activity maintains steady pace
Contact: Heather Woolwine
CHARLESTON –The Medical University of South Carolina (MUSC) continues to lead the state in biomedical research with more than $232 million in grant support from outside sources, including more than $92 million from the National Institutes of Health (NIH).
Despite significant decreases in federally-funded research, MUSC remained competitively positioned for the 4th straight and noted an increase in corporate-sponsored research. The university also earned unprecedented, simultaneous renewals for three NIH Centers of Biomedical Research Excellence (COBRE) in cardiovascular, oral health, and lipidomics research, totaling more than $16 million. Research programs in Neurosciences and Psychiatry and Behavioral Sciences. were again ranked among the top seven in the country for NIH funding.
“Sequestration and other pressures on federal funding for research continue to slow research development efforts, but the research teams continue to sustain their research programs. I believe this ability to compete for funding in these times is a reflection of the many talented individuals we have at MUSC and the commitment of all of those engaged with our research and discovery mission,” said Stephen M. Lanier, Ph.D., MUSC associate provost for research and chief scientific officer. “It is also important to recognize that in addition to the discovery of new therapies and development of new medical devices, this research funding is an important contributor to the regional economy, as it is estimated that each NIH dollar generates $2.21 in new state business activity.”
Other notable awards earned this year include:
- a Department of Defense grant of more than $10 million to study the reduction in society risk among military veterans
- NIH funds to establish the Multidisciplinary Clinical Research Center for Rheumatic Diseases in African Americans and multiple, high-profile grants for research training and workforce development
- a $4 million SmartState Endowed Center in Translational Biomedical Informatics grant as part of the SmartState Centers of Economic Excellence Program (http://smartstatesc.org/)
Several MUSC faculty members were recognized for their research contributions. Rosalie Crouch, Ph.D. was recognized with the 2013 Governor’s Award for Excellence in Scientific Research for her leadership, significant scientific achievements and expertise in the field of vision research; Robert J. Adams, M.D., received the David G. Sherman Lecture Award for lifetime contributions to the stroke field from the American Heart/American Stroke Association; and Marc Chimowitz, M.D., received the William M. Feinberg Award for Clinical Excellence in Stroke from the American Heart Association/American Stroke Association, recognizing ongoing contributions to the investigation and management of stroke.
Founded in 1824 in Charleston, The Medical University of South Carolina is the oldest medical school in the South. Today, MUSC continues the tradition of excellence in education, research, and patient care. MUSC educates and trains more than 3,000 students and residents, and has nearly 13,000 employees, including approximately 1,500 faculty members. As the largest non-federal employer in Charleston, the university and its affiliates have collective annual budgets in excess of $1.7 billion. MUSC operates a 750-bed medical center, which includes a nationally recognized Children's Hospital, the Ashley River Tower (cardiovascular, digestive disease, and surgical oncology), Hollings Cancer Center (one of 66 National Cancer Institute designated centers) and a leading Institute of Psychiatry. For more information on academic information or clinical services, visit www.musc.edu. For more information on hospital patient services, visit www.muschealth.com.